State of Art

  • D. Marrano
  • O. Campione
  • V. M. Greco
Conference paper

Abstract

In recent years the incidence of pancreatic fistulas has radically increased. The reasons underlying this increase can be mainly attributed to the progress and development of new surgical and anesthesiologic techniques and, in particular, to the following specific factors: an increase in the use of radical surgery for malignant pathologies which affect abdominal organs; a more frequent recourse to surgery in the case of pancreatic phlogosis and subsequent complications; the higher survival rate of polytraumatized patients with severe liver, pancreatic and duodenal lesions and, finally, the greater use of intraperitoneal drainage in the case of surgery performed on the liver, the biliary system and on the pancreas.

Keywords

Pancreatitis Dehydration Bicarbonate Statin Octreotide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahren B, Tranberg KG, Bengmark S (1988) Treatment of pancreatic fistula with the somato-statin analogue SMS 201 – 995. Br J Surg 75:718PubMedCrossRefGoogle Scholar
  2. Bartoli F, Arnone GB, Ravera G et al. (1991) Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis rea-garding 15 years of literature. Anticancer Res 11:1831–1848PubMedGoogle Scholar
  3. Bonnichon Ph, Tong JZ, Ortega D et al. (1988) Fistules pancreatique aprés pancreatectomy gauche. J Chir (Paris) 125 (5) :321–326Google Scholar
  4. Bruining HA (1986) A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula. Pancreas 1 (2) : 188 – 190PubMedGoogle Scholar
  5. Buchler M (1992) Role of octerotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163:125–131PubMedCrossRefGoogle Scholar
  6. Campione O, Greco VM, Casadei R et al. (1989) Treatment of pancreatic fistulas with soma-tostatin. Atti 1st IGSC Joint Meeting of Surgeons and Gastroenterologists, Amsterdam, 31 Aug–2 Sept (1989)Google Scholar
  7. Campione O, Casadei R, Greco VM et al. (1992) Le fistole pancreatiche: terapia medica con somatostatina long-acting, SIMAD 5 ’ Bologna, 31 March ’ 4 June 1992Google Scholar
  8. Fielding GA, McLatchie GR, Wilson C et al (1989) Acute pancreatites and pancreatic fistula formation. Br J Surg 76 :1126 –1128PubMedCrossRefGoogle Scholar
  9. Gripon S, Bouillot JL, Rolland E et al. (1988) Fistules pancréatiques aprés duodénopancréatec-tomie céphalique. J Chir (Paris) 125 (3): 161–165Google Scholar
  10. Gullo L (1991) Effect of octreotide in external pancreatic fistula. Am J Gastroenterol 86 (7) : 892–894PubMedGoogle Scholar
  11. Lansden FT, Adams DB, Anderson MC (1989) Treatment of external pancreatic fistula with somatostatin. Am Surg 55:695 – 698PubMedGoogle Scholar
  12. Lipsett PA, Cameron JL (1992) Internal pancreatic fistula. Am J Surg 163:216 – 220PubMedCrossRefGoogle Scholar
  13. Marrano D (1983) Le fistola pancreatica. Archivio ed Atti delia Società Italiana di Chirurgia, 85th congress, Palermo, 12–15 Oct 1983Google Scholar
  14. Marrano D, Campione O, Greco VM (1987) Impiego della somatostatina in chirurgia pancreatica. Atti dell’VIII Congresso Nazionale Biennale della Sezione Italiana del Collegium Internationale Chirurgiae Digestivae, Bologna, 18–21 March 1987Google Scholar
  15. Marrano D, Campione O, Greco VM (1988) Impiego della somatostatina nelle fistole pancreatiche Estratto da. Gastroenterol Clin XVII [Suppl 3]Google Scholar
  16. Prinz RA, Pickleman J, Hoffmann JP (1988) Treatment of pancreatico cutaneous fistulas with a somatostatin analog. Am J Surg 155:36 – 42PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • D. Marrano
  • O. Campione
  • V. M. Greco

There are no affiliations available

Personalised recommendations